guaifenesin and dextromethorphan hbr

Generic: guaifenesin and dextromethorphan hbr

Labeler: target corporation
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name guaifenesin and dextromethorphan hbr
Generic Name guaifenesin and dextromethorphan hbr
Labeler target corporation
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

dextromethorphan hydrobromide 60 mg/1, guaifenesin 1200 mg/1

Manufacturer
Target Corporation

Identifiers & Regulatory

Product NDC 11673-267
Product ID 11673-267_b50d26f2-6f4d-4430-9f6c-4d10bc893e75
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA206941
Listing Expiration 2026-12-31
Marketing Start 2024-07-04

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 11673267
Hyphenated Format 11673-267

Supplemental Identifiers

RxCUI
1099074
UNII
9D2RTI9KYH 495W7451VQ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name guaifenesin and dextromethorphan hbr (source: ndc)
Generic Name guaifenesin and dextromethorphan hbr (source: ndc)
Application Number ANDA206941 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
  • 1200 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (11673-267-05) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (11673-267-57) / 28 TABLET, EXTENDED RELEASE in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (11673-267-60) / 42 TABLET, EXTENDED RELEASE in 1 BOTTLE
source: ndc

Packages (3)

Ingredients (2)

dextromethorphan hydrobromide (60 mg/1) guaifenesin (1200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b50d26f2-6f4d-4430-9f6c-4d10bc893e75", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1099074"], "spl_set_id": ["15434143-ab8e-4cf9-e063-6394a90a2388"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-267-05)  / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "11673-267-05", "marketing_start_date": "20240704"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-267-57)  / 28 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "11673-267-57", "marketing_start_date": "20240704"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-267-60)  / 42 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "11673-267-60", "marketing_start_date": "20240704"}], "brand_name": "Guaifenesin and Dextromethorphan HBr", "product_id": "11673-267_b50d26f2-6f4d-4430-9f6c-4d10bc893e75", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "11673-267", "generic_name": "Guaifenesin and Dextromethorphan HBr", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Dextromethorphan HBr", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "60 mg/1"}, {"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA206941", "marketing_category": "ANDA", "marketing_start_date": "20240704", "listing_expiration_date": "20261231"}